Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgicel® Versus Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding (HMB): Randomised Controlled Trial

NCT03176992 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03176992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgicel® Versus Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding (HMB): Randomised Controlled Trial
Lead sponsor
Cairo University
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2015
Completion date
February 28, 2018
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial hyperplasia